Hyderabad: Bharat Biotech on Tuesday said it expects approval for its Covid-19 vaccine Covaxin from the World Health Organisation for Emergency Use Authorisation (EUA) during July-September.
The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.
“Application for EUL has been submitted to WHO-Geneva, regulatory approvals are expected July-September 2021,” it said in a release. The city-based vaccine maker said it has got EUA in 13 countries with more to follow.
Most countries recommend vaccinations against Covid-19. Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country-specific travel restrictions, Bharat Biotech said.
(Follow Money9 for latest Personal finance stories and Market Updates)
In a joint term insurance plan, not many insurers provide add-on covers along with a primary joint life insurance plan
So far, there is some evidence of a change in consumption pattern based on high-frequency consumption indicators for consumers in advanced economies
We should see more small investors take to ETF and passive investing in certain categories such as large-cap equities where active funds are lagging
Both Centre and the states are overly dependent on petroleum taxes. They may not ease their grip on them